| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Entera Bio Ltd. | Director | Stock Option (right to buy) | 108K | Jan 1, 2024 | Direct | ||
| Protara Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 10K | Jun 7, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| TARA | Protara Therapeutics, Inc. | Jun 7, 2024 | 1 | $0 | 4 | Jun 10, 2024 | Director |
| ENTX | Entera Bio Ltd. | Jan 1, 2024 | 1 | $0 | 4 | Jan 3, 2024 | Director |
| TARA | Protara Therapeutics, Inc. | Jun 7, 2023 | 1 | $0 | 4 | Jun 8, 2023 | Director |
| ENTX | Entera Bio Ltd. | Jan 2, 2023 | 1 | $0 | 4 | Jan 4, 2023 | Director |
| TARA | Protara Therapeutics, Inc. | Jun 8, 2022 | 1 | $0 | 4 | Jun 9, 2022 | Director |
| ENTX | Entera Bio Ltd. | Jan 1, 2022 | 2 | $0 | 4 | Jan 11, 2022 | Director |
| ENTX | Entera Bio Ltd. | Jan 1, 2022 | 0 | $0 | 3 | Jan 11, 2022 | Director |
| TARA | Protara Therapeutics, Inc. | Jun 9, 2021 | 1 | $0 | 4 | Jun 10, 2021 | Director |